APA (7th ed.) Citation

YH, T., JW, L., JI, T., YJ, L., HF, H., FH, C., . . . FC, L. (2025). Molecular Hydrogen as an Adjuvant Therapy in Comorbid Sjögren's Syndrome, SLE, and ILD: A Case Report on Immune Modulation and Fatigue Reduction. In vivo (Athens, Greece), 39(4), 2228. https://doi.org/10.21873/invivo.14018

Chicago Style (17th ed.) Citation

YH, Tsai, et al. "Molecular Hydrogen as an Adjuvant Therapy in Comorbid Sjögren's Syndrome, SLE, and ILD: A Case Report on Immune Modulation and Fatigue Reduction." In Vivo (Athens, Greece) 39, no. 4 (2025): 2228. https://doi.org/10.21873/invivo.14018.

MLA (9th ed.) Citation

YH, Tsai, et al. "Molecular Hydrogen as an Adjuvant Therapy in Comorbid Sjögren's Syndrome, SLE, and ILD: A Case Report on Immune Modulation and Fatigue Reduction." In Vivo (Athens, Greece), vol. 39, no. 4, 2025, p. 2228, https://doi.org/10.21873/invivo.14018.